Free Trial
NASDAQ:KRRO

Korro Bio (KRRO) Stock Price, News & Analysis

Korro Bio logo
$13.44 -0.32 (-2.33%)
As of 01:50 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About Korro Bio Stock (NASDAQ:KRRO)

Advanced

Key Stats

Today's Range
$13.08
$13.99
50-Day Range
$9.15
$14.39
52-Week Range
$5.20
$55.89
Volume
78,064 shs
Average Volume
199,833 shs
Market Capitalization
$193.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.71
Consensus Rating
Moderate Buy

Company Overview

Korro Bio Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
63rd Percentile Overall Score

KRRO MarketRank™: 

Korro Bio scored higher than 63% of companies evaluated by MarketBeat, and ranked 331st out of 869 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Korro Bio has received a consensus rating of Moderate Buy. The company's average rating score is 2.82, and is based on 2 strong buy ratings, 6 buy ratings, 2 hold ratings, and 1 sell rating.

  • Upside Potential

    Korro Bio has a consensus price target of $16.71, representing about 24.4% upside from its current price of $13.44.

  • Amount of Analyst Coverage

    Korro Bio has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Korro Bio's stock forecast and price target.
  • Earnings Growth

    Earnings for Korro Bio are expected to decrease in the coming year, from ($5.38) to ($6.05) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Korro Bio is -1.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Korro Bio is -1.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Korro Bio has a P/B Ratio of 1.62. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Korro Bio's valuation and earnings.
  • Percentage of Shares Shorted

    8.70% of the float of Korro Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Korro Bio has a short interest ratio ("days to cover") of 11.45, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Korro Bio has recently increased by 6.90%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Korro Bio does not currently pay a dividend.

  • Dividend Growth

    Korro Bio does not have a long track record of dividend growth.

  • News Sentiment

    Korro Bio has a news sentiment score of 0.95. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.78 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Korro Bio this week, compared to 3 articles on an average week.
  • Search Interest

    Only 1 people have searched for KRRO on MarketBeat in the last 30 days. This is a decrease of -89% compared to the previous 30 days.
  • Cluster Insider Buying

    9 insiders have purchased shares of Korro Bio in the last three months. Multiple insiders buying is a strong bullish signal.

  • Net Insider Buying

    Over the last three months, insiders have purchased a net $18,412,560.00 in company stock, which represents 9.5041% of the company's market cap.

  • Insider Buying vs. Insider Selling

    In the past three months, Korro Bio insiders have bought more of their company's stock than they have sold. Specifically, they have bought $18,412,560.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    4.80% of the stock of Korro Bio is held by insiders.

  • Percentage Held by Institutions

    13.18% of the stock of Korro Bio is held by institutions.

  • Read more about Korro Bio's insider trading history.
Receive KRRO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Korro Bio and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

KRRO Stock News Headlines

Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall of Fame Trader Jon Najarian now says EVERYONE is missing an even bigger story about the SpaceX IPO… That it's just the start of an Elon Musk $44 trillion "Superconvergence…" An event that could kick off as soon as June 12th.tc pixel
See More Headlines

KRRO Stock Analysis - Frequently Asked Questions

Korro Bio's stock was trading at $8.01 at the start of the year. Since then, KRRO stock has increased by 67.7% and is now trading at $13.4350.

Korro Bio, Inc. (NASDAQ:KRRO) released its earnings results on Thursday, May, 7th. The company reported ($1.69) EPS for the quarter, missing analysts' consensus estimates of ($1.60) by $0.09. Korro Bio had a negative net margin of 1,834.48% and a negative trailing twelve-month return on equity of 117.86%.

Korro Bio (KRRO) raised $90 million in an initial public offering on Thursday, October 3rd 2019. The company issued 6,000,000 shares at a price of $14.00-$16.00 per share.

Top institutional investors of Korro Bio include Affinity Asset Advisors LLC (4.90%), ADAR1 Capital Management LLC (3.75%), Renaissance Technologies LLC (0.94%) and Kalehua Capital Management LLC (0.76%). Insiders that own company stock include Lynx1 Capital Management Lp, Rick Yang, Paul Edward Walker, Mohamad Makhzoumi, Enterprise Associates 17 New, Anthony A Jr Florence, Venture Opportunity Fund Atlas, David L Lucchino and Vineet Agarwal.
View institutional ownership trends
.

Shares of KRRO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Korro Bio investors own include Tesla (TSLA), NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Home Depot (HD).

Company Calendar

Last Earnings
5/07/2026
Today
5/28/2026
Next Earnings (Estimated)
8/11/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:KRRO
Previous Symbol
NASDAQ:KRRO
CIK
1703647
Fax
N/A
Employees
70
Year Founded
2018

Price Target and Rating

High Price Target
$23.00
Low Price Target
$10.00
Potential Upside/Downside
+24.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.82
Research Coverage
11 Analysts

Profitability

EPS (Trailing Twelve Months)
($11.67)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$117.26 million
Net Margins
-1,834.48%
Pretax Margin
-2,935.09%
Return on Equity
-117.86%
Return on Assets
-71.04%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
8.13
Quick Ratio
8.13

Sales & Book Value

Annual Sales
$6.39 million
Price / Sales
30.32
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$8.29 per share
Price / Book
1.62

Miscellaneous

Outstanding Shares
14,420,000
Free Float
13,731,000
Market Cap
$193.73 million
Optionable
No Data
Beta
3.07

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:KRRO) was last updated on 5/28/2026 by MarketBeat.com Staff.
From Our Partners